JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, published by Taylor & Francis Inc, is a pivotal platform for disseminating cutting-edge research in the field of liquid chromatography and its applications across various disciplines including analytical chemistry, biochemistry, and pharmaceutical science. With an ISSN of 1082-6076 and an E-ISSN of 1520-572X, this journal serves as an essential resource for researchers, professionals, and students committed to advancing the understanding and development of chromatographic techniques. Despite not being an open access publication, the journal features a robust submission process from 1996 to 2024, ensuring comprehensive coverage of historical and contemporary methodologies. Notably, it has achieved rankings in the Q3 and Q4 quartiles across various categories, reflecting its reputable position in the field. It’s recognized within key databases, with Scopus ranks indicating its influential role in areas such as pharmaceutical science and analytical chemistry. This journal is not only a cornerstone for specialized studies but also fosters interdisciplinary collaborations, making it an invaluable asset for the scientific community.

Biochemia Medica is a premier open-access journal that has been at the forefront of advancing knowledge in the fields of medical biochemistry and laboratory medicine since its inception in 2006. Published by the Croatian Society of Medical Biochemistry & Laboratory Medicine, this journal serves a vital role in disseminating high-quality research findings and reviews that contribute to the understanding of biochemical processes in health and disease. With an impressive performance in the Scopus ranking, it holds a Q2 quartile category in both medical biochemistry and clinical biochemistry for 2023, reflecting its commitment to scholarly excellence and relevance in the field. As an open-access journal, Biochemia Medica ensures that research is freely accessible, fostering collaboration and innovation among researchers, healthcare professionals, and students globally. Positioned within a rapidly evolving scientific landscape, this journal is dedicated to bridging the gap between laboratory research and clinical application, making it an indispensable resource for anyone interested in the intersections of biochemistry and medicine.

The European Journal of Pharmaceutical Sciences is a prestigious academic journal dedicated to advancing the field of pharmaceutical science. Published by Elsevier, the journal boasts an impressive impact factor and is categorized in the Q1 quartile for pharmaceutical science as of 2023, signifying its influence and reputation within the academic community. With a Scopus ranking of #20 out of 183 in the fields of pharmacology, toxicology, and pharmaceutics, the journal provides a vital platform for researchers and practitioners to disseminate innovative studies and groundbreaking research that push the boundaries of drug development and delivery. Based in the Netherlands and operating since 1993, the journal seeks to cover a broad scope of topics related to pharmaceutical sciences, encouraging rigorous evaluations and discussions that enhance the understanding and application of this critical field. The absence of open access underscores the commitment to maintaining high scholarly standards, while still offering avenues for libraries and institutions to provide access to cutting-edge research. As the journal converges towards its 2024 milestones, it continuously aims to foster a vibrant exchange of knowledge among its diverse readership, comprising committed researchers, professionals, and students.

JOURNAL OF ANALYTICAL CHEMISTRY, published by PLEIADES PUBLISHING INC, stands as a pivotal resource in the field of analytical chemistry, offering an innovative platform for researchers, professionals, and students to advance their knowledge and contribute to the discourse within the discipline. With an ISSN of 1061-9348 and an E-ISSN of 1608-3199, this journal features a focused exploration of analytical methodologies, instrumentation developments, and applications across various domains, contributing to practical and theoretical advancements in the field. Currently ranked in the Q3 category in Analytical Chemistry with a Scopus rank of #111 out of 156, it provides critical insights and innovation strategies for professionals aiming to enhance their analytical capabilities. Access to the journal is through standard subscription models, and it covers an extensive range of topics pertinent to the discipline from 1996 to 2024. Engage with the JOURNAL OF ANALYTICAL CHEMISTRY to be part of a vibrant research community dedicated to push the boundaries of analytical practices.

AAPS Journal, published by Springer in the United States, is a leading peer-reviewed journal dedicated to the advancement of research in the field of Pharmaceutical Sciences. With an impressive Q1 rank in its category and a position within the 81st percentile of Scopus rankings, it serves as a vital resource for researchers and professionals seeking to disseminate impactful findings and innovative methodologies. The journal publishes high-quality original research, review articles, and technical reports aimed at addressing the multifaceted challenges in pharmacology, toxicology, and pharmaceutics. Operating under an Open Access model, AAPS Journal ensures broad dissemination of knowledge, contributing to the enhanced visibility and accessibility of research outputs. With a publication window spanning from 1999 to 2024, it continues to shape the future of pharmaceutical research and its applications. Researchers, students, and industry professionals will find a valuable repository of cutting-edge knowledge in this esteemed journal.

DRUGS IN R&D is a premier open access journal dedicated to advancing the field of pharmacology and drug development. Published by Springer International Publishing AG, this journal has been a valuable resource for researchers and professionals since its inception in 1999, contributing critical insights into the pharmacological sciences. With an impressive Impact Factor reflecting its significance, DRUGS IN R&D ranks in the Q2 quartile for Pharmacology, according to 2023 metrics, and ranks #151 out of 313 in the field of pharmacology and toxicology on Scopus. This journal offers an open access format, ensuring high visibility and accessibility of research findings to a global audience, supporting the intrepid pursuit of knowledge in drug research and development. By facilitating comprehensive discussions and innovative research findings, DRUGS IN R&D plays a crucial role in shaping the future landscape of pharmacological studies and advancements.

The Journal of Pharmaceutical and Biomedical Analysis, published by ELSEVIER and available in print and online formats, stands as a pivotal source of knowledge in the realms of Analytical Chemistry, Clinical Biochemistry, Drug Discovery, and Pharmaceutical Science. With an ISSN of 0731-7085 and an e-ISSN of 1873-264X, this journal is dedicated to publishing high-quality research that advances the understanding and development of analytical techniques in pharmaceuticals and biomedicine. The journal has earned a solid reputation, reflected in its Q2 category rankings across five distinct fields for 2023, and boasts impressive Scopus rankings, signaling its robust impact within the academic community. The Journal of Pharmaceutical and Biomedical Analysis serves as an essential resource for researchers, professionals, and students alike, providing actionable insights and fostering innovation that can directly influence future advancements in drug development and biomedical applications.

Welcome to the Journal of Chromatographic Science, a premier publication dedicated to advancing the scientific understanding of chromatographic techniques and their applications across various disciplines. Published by Oxford University Press Inc, this journal, with its ISSN 0021-9665 and E-ISSN 1945-239X, has been disseminating innovative research since 1963, serving as a vital resource for researchers, industry professionals, and academic scholars in the fields of Analytical Chemistry and Medicine. As evidenced by its 2023 Scopus ranking, the journal stands at the Q3 quartile in both its primary disciplines, highlighting its relevance and contribution to ongoing research. The journal promotes high-quality, peer-reviewed articles that aim to foster knowledge and encourage the practical application of chromatographic science. While it operates under a traditional subscription model, the valuable insights it offers are essential for those seeking to enhance their expertise and stay at the forefront of chromatographic methodologies. Join our community of scholars as we explore the complexities and innovations in chromatographic science, paving the way for future discoveries.

ANALYTICAL LETTERS is a reputable journal published by Taylor & Francis Inc, focusing on the dynamic fields of analytical chemistry, biochemistry, and clinical biochemistry. With an ISSN of 0003-2719 and an E-ISSN of 1532-236X, the journal has been a platform for scholarly articles since its inception in 1967, and is set to continue its contribution to the scientific community until 2024. Despite its classification in Q3 across various categories as of 2023, including analytical chemistry and spectroscopy, ANALYTICAL LETTERS maintains a significant impact within its field, evidenced by its moderate rankings within Scopus. This journal serves as a vital resource for researchers and professionals seeking to explore recent advancements in analytical methodologies, instrumentation, and applications, facilitating the dissemination of critical insights in laboratory practices. With access primarily through institutional subscriptions, it remains positioned as a crucial tool for those advancing knowledge and innovation in analytical sciences.

BIOPHARM INTERNATIONAL, published by Advanstar Communications Inc, is a notable journal in the realms of biotechnology and pharmaceutical sciences, with an ISSN of 1542-166X and an E-ISSN of 1939-1862. Since its inception in 2002, the journal has established a platform for the dissemination of innovative research and comprehensive reviews that delve into the intricate interface of biopharmaceutical development and technological advances. Despite its current standing in the Q4 quartile for both Biotechnology and Pharmaceutical Science categories, its commitment to quality and relevance continues to attract contributions from a diverse cadre of researchers and academics. The journal operates within the US, catering to a global audience, and focuses on themes ranging from drug formulation to biotechnological breakthroughs. While the journal currently offers limited Open Access options, it remains a critical resource for those looking to navigate the evolving landscape of pharmaceutical innovations. Researchers, professionals, and students alike will find valuable insights that are essential for staying abreast of key trends and advancements in their fields.